GeneLife Expands GeneAI Forecast With New Cancer Risk Prediction Models
AI-Driven Risk Prediction for Breast, Prostate and Pancreatic CancersTOKYO, Dec. 05, 2025 (GLOBE NEWSWIRE) -- A.D.A.M. Innovations Co. (Japanese Name:...
Genetic Testing
Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome
Phase 2 clinical trial initiated to evaluate SEMA3A mAb as potential treatment for Alport syndromeMilestone payment to Evotec expected upon...
MyOme and Ms.Medicine Announce Strategic Partnership to Redefine Personalized Primary Care Through Genomics
MENLO PARK, Calif. and CINCINNATI, Dec. 3, 2025 /PRNewswire/ -- MyOme, a leading clinical whole-genome testing and polygenic risk modelling...
Hydreight Reports 132% YoY Revenue Increase in Q3 2025 and Fourth Consecutive Quarter of Profitability, Highlighting Strong Multi-Vertical Performance
“The quarter reflects broad growth across all verticals, expanding VSDHOne adoption, and strategic investments aimed at supporting margin improvement and...
Illume Fertility Launches Comprehensive Online Finance Hub to Help Patients Navigate the Cost of Fertility Care
New resource provides clear guidance on insurance, financing, grants, and medication savings programs to make family building more accessibleNORWALK, Conn.,...
Eisai Completes Rolling Submission to US FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status
LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home injection from...
MyOme Launches First Integrated Polygenic Risk Score for Prostate Cancer to Advance Early Detection and Personalized Prevention
New whole-genome test uncovers hidden genetic risk beyond traditional screening, empowering earlier and more precise care for millions of men....
The Rise of Advanced Maternal Age IVF: BaseCare Medical’-B(2170.HK) AI “Undisturbed Culture” Empowers Intelligent Assisted Reproduction
SUZHOU, China, Nov. 19, 2025 /PRNewswire/ -- Data from the keynote report at the 18th Annual Conference of the Chinese...
Pinnacle Fertility Expands National Network with the Addition of Tulsa Fertility Center
SCOTTSDALE, Ariz., Nov. 14, 2025 /PRNewswire/ -- Tulsa Fertility Center, a leading provider of reproductive medicine and one of Oklahoma's...
Myriad Genetics to Highlight Genetic Testing Advancements at 2025 National Society of Genetic Counselors Annual Conference
SALT LAKE CITY, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing...
Surpassing Apple Fitness, a Virtual Unknown Wins Best Health App of the Year
A lifesaving breast health app named 'Know Your Lemons' wins top prize—with extra features for the workplace to support employees...
Genomic Prediction Files Federal Lawsuit to Protect Trade Secrets and Intellectual Property and Enforce Its Rights
NEWARK, N.J., Oct. 23, 2025 /PRNewswire/ -- Genomic Prediction Inc. ("GP"), a leader in advanced genetic testing and reproductive genomics, announced...
Inception Fertility Commends President Trump for Encouraging Employers to Expand Fertility Benefits
In a press conference, the President called on US employers to expand healthcare benefits to include IVF HOUSTON, Oct. 17,...
A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan
ROLLE, Switzerland and TOKYO, Oct. 16, 2025 /PRNewswire/ -- A.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS (Nasdaq: SOPH),...
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx Constellation outperformed orthogonal methods in...
TruDiagnostic Awarded NIH SBIR Grant to Advance Breakthrough Epigenetic Diagnostic Technology
LEXINGTON, Ky., Oct. 7, 2025 /PRNewswire/ -- TruDiagnostic, a leader in epigenetic testing and health analytics, announced today it has...
Golden Helix Receives a NIH SBIR Phase 2 Grant
Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options BOZEMAN, Mont., Oct. 7, 2025 /PRNewswire/ -- Golden Helix, Inc. announced that it...
Hypha Labs and Tryptomics Launch Phase II of Strategic Partnership, Pairing Patented Mushroom Accelerator(TM) with World-Class Internal Quality Control & Fungal Genomics
LAS VEGAS, NV / ACCESS Newswire / October 1, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a biotechnology company pioneering the...
Quintessence Psychiatry Adopts Mentavi’s Mental Health Diagnostic Evaluation to Offer More Rigorous, Timely ADHD Assessments in Private Practice
Early Patient Feedback Points to Clearer Understanding of Results and Smoother Treatment Planning GRAND RAPIDS, MICHIGAN / ACCESS Newswire /...
SumHealth and Nucleus Genomics Partner to Bring Whole-Genome DNA Testing Into Healthcare Infrastructure
Partnership Makes Advanced, Clinical-Grade Genetic Insights Affordable and Accessible Through Hospitals, Pharmacies and Healthcare Systems Nationwide CHARLOTTE, NORTH CAROLINA /...